Work

Early circulating tumor (ct) DNA dynamics and efficacy of lorlatinib: Analysis from the CROWN study.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.9011

Authors: Ross A. Soo, Jean-Francois Martini, Anthonie J. van der Wekken, Shunsuke Teraoka, Alice T. Shaw, Deborah Shepard, Anna Maria Calella, Anna Polli, Francesca Toffalorio, Pascale Tomasini, Chao-Hua Chiu, Dariusz Kowalski, Hye Ryun Kim, Benjamin J. Solomon

Institutions: National University Cancer Institute, Singapore, Pfizer (United States), University Medical Center Groningen, University of Groningen, Wakayama Medical University, Massachusetts General Hospital, Aix-Marseille Université, Taipei Veterans General Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Yonsei University, Peter MacCallum Cancer Centre

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170978437

Cites:

Cited by: 6

Related to: 10